Stay updated on Tezacaftor/Ivacaftor Combo in CF: Clinical Trial
Sign up to get notified when there's something new on the Tezacaftor/Ivacaftor Combo in CF: Clinical Trial page.

Latest updates to the Tezacaftor/Ivacaftor Combo in CF: Clinical Trial page
- Check2 days agoChange DetectedThe page footer now displays Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedLocations are consolidated under a unified 'Locations' section listing multiple states and the District of Columbia, reflecting a revision (v3.3.3). The previous per-state location entries (v3.3.2) have been removed.SummaryDifference2%

- Check52 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and shows Revision: v3.3.2; the previous PubMed description and Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check59 days agoChange DetectedThe funding-status notice at the top of the page has been removed, removing a general operating-status warning without altering the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedStudy record details, including title, conditions, intervention, eligibility criteria, and locations, appear unchanged between the screenshots. No substantive content updates were observed.SummaryDifference0.3%

- Check102 days agoChange DetectedMajor change: version updated to v3.2.0 with a government-operating-status notice; previous version v3.1.0 was removed.SummaryDifference4%

Stay in the know with updates to Tezacaftor/Ivacaftor Combo in CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezacaftor/Ivacaftor Combo in CF: Clinical Trial page.